CHEMBIO DIAGNOSTICS INC (CEMI) Stock Earnings & Estimates
NASDAQ:CEMI - US1635722093 - Common Stock
0.455 USD
+0 (+0.22%)
0.4311 USD
-0.02 (-5.25%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 32.47M -5.77% | 47.818M 47.27% | 49.522M 3.56% | |
| EBITDA YoY % growth | -19.25M -80.07% | -21.074M -9.48% | -17.849M 15.31% | |
| EBIT YoY % growth | -21.95M -74.07% | -24.005M -9.36% | -20.402M 15.01% | |
| Operating Margin | -67.60% | -50.20% | -41.20% | |
| EPS YoY % growth | -1.28 -62.03% | -1.38 -7.81% | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.21 12.50% | % | ||
| Q2 2022 Q2Q % growth | -0.23 48.89% | % | ||
| Q1 2022 Q2Q % growth | -0.29 -31.82% | -0.21 | -0.08 | -35.39% |
| Q4 2021 Q2Q % growth | -0.47 -34.29% | -0.21 | -0.26 | -124.77% |
| Q3 2021 Q2Q % growth | -0.24 14.29% | -0.19 | -0.05 | -23.84% |
| Q2 2021 Q2Q % growth | -0.45 -12.50% | -0.37 | -0.08 | -20.32% |
| Q1 2021 Q2Q % growth | -0.22 12.00% | -0.32 | 0.10 | 31.89% |
| Q4 2020 Q2Q % growth | -0.35 -45.83% | -0.28 | -0.07 | -24.02% |
| Q3 2020 Q2Q % growth | -0.28 -27.27% | -0.27 | -0.01 | -5.58% |
| Q2 2020 Q2Q % growth | -0.40 -110.53% | -0.40 | 0.00 | 0.72% |
| Q1 2020 Q2Q % growth | -0.25 -78.57% | -0.23 | -0.02 | -7.74% |
| Q4 2019 Q2Q % growth | -0.24 | -0.25 | 0.01 | 3.96% |
| Q3 2019 Q2Q % growth | -0.22 | -0.17 | -0.05 | -26.87% |
| Q2 2019 Q2Q % growth | -0.19 | -0.16 | -0.03 | -22.15% |
| Q1 2019 Q2Q % growth | -0.14 | -0.16 | 0.02 | 9.70% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 10.344M -49.72% | % | ||
| Q3 2022 Q2Q % growth | 11.2M -7.12% | % | ||
| Q2 2022 Q2Q % growth | 9.161M 41.77% | % | ||
| Q1 2022 Q2Q % growth | 18.817M 115.79% | 12.036M | 6.781M | 56.34% |
| Q4 2021 Q2Q % growth | 20.574M 101.11% | 13.821M | 6.753M | 48.86% |
| Q3 2021 Q2Q % growth | 12.058M 17.41% | 12.712M | -653.56K | -5.14% |
| Q2 2021 Q2Q % growth | 6.462M 26.46% | 7.138M | -675.89K | -9.47% |
| Q1 2021 Q2Q % growth | 8.72M 27.11% | 8.354M | 366K | 4.38% |
| Q4 2020 Q2Q % growth | 10.23M 49.34% | 5.885M | 4.345M | 73.83% |
| Q3 2020 Q2Q % growth | 10.27M 5.66% | 3.993M | 6.277M | 157.20% |
| Q2 2020 Q2Q % growth | 5.11M -48.33% | 7.018M | -1.908M | -27.19% |
| Q1 2020 Q2Q % growth | 6.86M -19.67% | 7.886M | -1.026M | -13.01% |
| Q4 2019 Q2Q % growth | 6.85M | 8.722M | -1.872M | -21.46% |
| Q3 2019 Q2Q % growth | 9.72M | 10.105M | -385K | -3.81% |
| Q2 2019 Q2Q % growth | 9.89M | 8.991M | 899K | 10.00% |
| Q1 2019 Q2Q % growth | 8.54M | 8.729M | -189K | -2.17% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |